USING DATA TO PREVENT OPIOID DIVERSION ACT

Remarks in Senate

Drugs: strengthen penalties on drug companies that fail to monitor and report suspicious opioid distribution practices and increase transparency of Federal oversight of opioid manufacturing and advertising, S3596 [11JN]

Enact (S. 2838), S3596 [11JN]

Reports filed

Provisions: Committee on the Judiciary (Senate) (S. 2838), S4035 [19JN]